TY - JOUR
T1 - Influence of 15-deoxyspergualin on activated lymphocytes
T2 - Comparison of heart and renal rat transplantation models
AU - Ueda, H.
AU - Itoh, S.
AU - Azuma, H.
AU - Kusaka, M.
AU - Katsuoka, Y.
PY - 1999
Y1 - 1999
N2 - Background. Among the immunological effects of 15-deoxyspergualin (DSG), its action on activated T lymphocytes with the interleukin 2 receptor (IL- 2R) is controversial. Materials and methods. To investigate this action, we used rat heart and rat renal transplantation models in which Brown Norway rats (BN) served as the organ donors and Lewis rats (LEW) as the organ recipients. DSG was administered intraperitoneally to the recipients immediately after the operation. The percentage of IL-2R-positive cells and of CD4- and CD8-positive cells in the recipient spleen or allograft was evaluated. Results. The average survival period (days) of the BN heart or renal allograft in hosts treated with DSG was significantly longer than that in the untreated hosts. In the heart transplantation model, DSG decreased the percentage of IL-2R-positive cells and increased the CD4/CD8 ratio in the allograft. By contrast, in the renal transplantation model, DSG suppressed the percentage of IL-2R-positive cells in the spleen, but influenced neither the percentage of IL-2R-positive cells nor the CD4/CD8 ratio in the allograft. Conclusion. DSG extended allograft survival significantly in both heart and renal transplantation models. However, the influence of DSG on IL- 2R-positive cells may be different in the two types of allografts.
AB - Background. Among the immunological effects of 15-deoxyspergualin (DSG), its action on activated T lymphocytes with the interleukin 2 receptor (IL- 2R) is controversial. Materials and methods. To investigate this action, we used rat heart and rat renal transplantation models in which Brown Norway rats (BN) served as the organ donors and Lewis rats (LEW) as the organ recipients. DSG was administered intraperitoneally to the recipients immediately after the operation. The percentage of IL-2R-positive cells and of CD4- and CD8-positive cells in the recipient spleen or allograft was evaluated. Results. The average survival period (days) of the BN heart or renal allograft in hosts treated with DSG was significantly longer than that in the untreated hosts. In the heart transplantation model, DSG decreased the percentage of IL-2R-positive cells and increased the CD4/CD8 ratio in the allograft. By contrast, in the renal transplantation model, DSG suppressed the percentage of IL-2R-positive cells in the spleen, but influenced neither the percentage of IL-2R-positive cells nor the CD4/CD8 ratio in the allograft. Conclusion. DSG extended allograft survival significantly in both heart and renal transplantation models. However, the influence of DSG on IL- 2R-positive cells may be different in the two types of allografts.
UR - http://www.scopus.com/inward/record.url?scp=0033064870&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033064870&partnerID=8YFLogxK
U2 - 10.1007/s101570050005
DO - 10.1007/s101570050005
M3 - Article
AN - SCOPUS:0033064870
SN - 1342-1751
VL - 3
SP - 29
EP - 33
JO - Clinical and Experimental Nephrology
JF - Clinical and Experimental Nephrology
IS - 1
ER -